Open Up! Says Sanofi Small Molecules Chief
This article was originally published in Scrip
Executive Summary
Sanofi SA says it is open to compound exchanges with other big pharma companies similar to that entered with AstraZeneca PLC earlier this month where the duo agreed to share 210,000 of their proprietary chemical compounds from their respective libraries in a joint effort to increase the number of leads for new medicines.